SCHEMBL30955263

SCHEMBL30955263

CCCCOC(=O)N1CCc2c1cncc2C(C)(C)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ BCHE P06276 1/20 0.34
▸ GPR119 Q8TDV5 7/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ SMYD3 Q9H7B4 1/20 0.32
▸ PLA2G2A P14555 2/20 0.31
▸ OPRD1 P41143 1/20 0.31
▸ OPRK1 P41145 1/20 0.31
▸ HRH2 P25021 1/20 0.31
▸ HRH1 P35367 1/20 0.31
▸ NOTUM Q6P988 1/20 0.30
▸ PTGDR2 Q9Y5Y4 1/20 0.30
▸ MAPT P10636 2/20 0.30
▸ TSHR P16473 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ NFKB1 P19838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30955311 0.81 UCHL1 (0.39) GPR119NOTUM
SCHEMBL30955178 0.70 BCHE (0.40) BCHEGPR119NOTUMKMT2A
SCHEMBL30955287 0.70 BCHE (0.46) SMN1; SMN2LMNAPOLBBCHEL3MBTL1
SCHEMBL5797625 0.68 RAB9A (0.63) SMN1; SMN2LMNAPOLBBCHEL3MBTL1
SCHEMBL30955229 0.67 ADORA1 (0.42) SMN1; SMN2LMNAPOLBGPR119MAPT
SCHEMBL29483712 0.66 SMN1; SMN2 (0.44) SMN1; SMN2LMNAPOLBBCHEL3MBTL1
SCHEMBL30913149 0.65 UCHL1 (0.48) GPR119
SCHEMBL8014966 0.65 BCHE (0.49) SMN1; SMN2LMNAPOLBBCHEL3MBTL1
SCHEMBL27749835 0.64 LMNA (0.45) SMN1; SMN2LMNAPOLBBCHEGPR119
SCHEMBL27749593 0.64 MEN1 (0.45) SMN1; SMN2LMNAPOLBGPR119L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4638441-A1 GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2025-10-29 — — EP disclosed
WO-2024133499-A1 GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES RHEINISCHE-FRIEDRICH-WILHELMS-UNIVERSITÄT BONN (DE) 2024-06-27 — — WO disclosed
Send feedback